4 completed, 3 terminated, 1 recruiting. 8 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 4, Terminated 3, Recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Desmopressin: new trials by email Literature Review of Desmopressin trials Research Report on Desmopressin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome Desmopressin, Dexamethasone - Cushing Syndrome | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 140 | 2024-12-12 | 2026-08-31 |
| A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults FE 201836, Desmopressin, Placebo oral solution - Nocturia | Phase 2 | Completed | Ferring Pharmaceuticals | 302 | 2017-07-27 | 2022-03-02 |
| Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older Desmopressin, Fesoterodine - Nocturia | Phase 2 / Phase 3 | Terminated | Mount Sinai Hospital, Canada | 4 | 2015-07-01 | 2016-11-15 |
| DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty DDAVP - Postoperative Ecchymosis | Phase 2 | Terminated | University Hospitals Cleveland Medical Center | 14 | 2013-12-01 | 2023-08-16 |
| Daytime Impact Sleep Study Desmopressin, Placebo (not active) - Nocturia | Phase 2 | Terminated | Ferring Pharmaceuticals | 5 | 2013-04-01 | 2015-04-27 |
| Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding Desmopressin - Colorectal Cancer, Rectal Bleeding | Phase 2 | Completed | Laboratorio Elea Phoenix S.A. | 30 | 2013-04-01 | 2017-08-24 |
| Perioperative Use of Desmopressin (DDAVP) in Breast Cancer Desmopressin - Breast Cancer | Phase 2 | Completed | Laboratorio Elea Phoenix S.A. | 21 | 2011-11-01 | 2015-08-28 |
| Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo Desmopressin, Placebo - Nocturia | Phase 2 | Completed | Ferring Pharmaceuticals | 116 | 2010-07-01 | 2012-05-25 |
Nocturia (4) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Cushing Syndrome (1) · Disease (1) · Ecchymosis (1) · Edema (1) · Gastrointestinal Hemorrhage (1)
Ferring Pharmaceuticals (3) · Laboratorio Elea Phoenix S.A. (2) · Mount Sinai Hospital, Canada (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University Hospitals Cleveland Medical Center (1)
United States (3) · Argentina (2) · Canada (2) · Belgium (1) · Czechia (1) · Germany (1) · Hungary (1) · Japan (1) · Poland (1) · United Kingdom (1)
Bahman Guyuron, MD (1) · Dra. Ruth Weinberg (1) · Enrique Roca, MD (1) · Harold P Drutz, MD (1) · Lynnette K Nieman, M.D. (1)
PMID 26306290, PMID 32166534, PMID 42535456
2016 (1)